About Cardiac Medical Devices Market in the US

Atrial fibrillation (AF), a common type of heart arrhythmia, is a heart condition when the heart beats too fast or too slow or in an irregular way. An estimation done by the Centers for Disease Control and Prevention (CDC) in 2015 shows that in the US 2.7-6.1 million people were diagnosed with AF. It is most common in the older population, among people aged 60 years or above. This condition occurs when the heart's ability to function reduces and there is a malfunction in the electrical impulses in the heart, which leads to sudden cardiac arrest or heart failure.
Cardiac output such as an irregularity in the ventricular rate can lead to diastolic dysfunction. Hence, to reduce the risk of irregular heartbeat, especially for people that are at a higher risk of arrhythmia or have recurrent arrhythmia, cardiac medical devices such as pacemaker or implantable cardioverter defibrillators (ICD) are used to help the heart's electrical activity and heart rhythm function. These devices are small and are placed below the collar bone. Heart attacks can also cause defects in the heart valves, which can be replaced by mechanical or tissue heart valves.

Technavio’s analysts forecast the cardiac medical devices market in the US to grow at a CAGR of 1.82% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the cardiac medical devices market in the US for 2016-2020. Cardiac medical devices that are included in this report are implanted in the heart through minimally invasive surgeries. To calculate the market size, the report considers the revenue generated from the sales of the products.

The market is divided into the following segments based on product type:
• Cardiac rhythm management (CRM) devices
• Cardiac assist devices
• Heart valve

Technavio's report, Cardiac Medical Devices Market in the US 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Boston Scientific
• LivaNova
• Medtronic
• St. Jude Medical

Other prominent vendors
• Abiomed
• Adam, Rouilly
• Advanced Instrumentations
• A.M.I. ITALIA
• Biotronik
• Cardioline
• Cardia International
• Cardiac Science (subsidiary of Opto Circuits)
• Colibri Heart Valve
• Corpuls
• Edwards Lifesciences
• EMTEL
• Fukuda Denshi
• HeartWare
• Innomed
• INSTRAMED
• MEDIANA
• M&B Electronic Instruments
• Medical ECONET
• Mindray Medical
• Physio Control
• PRIMEDIC
• Prestan
• Schiller
• Spectranetics
• SynCardia
• Symetis
• TTK Healthcare
• WNL Products

Market driver
• Prevalence of cardiac disorders
• For a full, detailed list, view our report

Market challenge
• High cost of cardiac devices
• For a full, detailed list, view our report

Market trend
• Increase in M&A
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.